Pub. Date : 2003 Sep 26
PMID : 12842891
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Morphine inhibited phosphorylation of ERK1/2 and p38 MAPK; in addition, morphine treatment in the presence of either ERK1/2 or p38 MAPK inhibitor (PD98059 or SB203580) resulted in an additive inhibition of IFN-gamma promoter activity. | Morphine | mitogen-activated protein kinase 3 | Mus musculus |
2 | Morphine inhibited phosphorylation of ERK1/2 and p38 MAPK; in addition, morphine treatment in the presence of either ERK1/2 or p38 MAPK inhibitor (PD98059 or SB203580) resulted in an additive inhibition of IFN-gamma promoter activity. | Morphine | mitogen-activated protein kinase 3 | Mus musculus |
3 | Morphine inhibited phosphorylation of ERK1/2 and p38 MAPK; in addition, morphine treatment in the presence of either ERK1/2 or p38 MAPK inhibitor (PD98059 or SB203580) resulted in an additive inhibition of IFN-gamma promoter activity. | Morphine | mitogen-activated protein kinase 3 | Mus musculus |
4 | In summary, our data indicate that morphine modulation of IFN-gamma promoter activity is mediated through two distinct cAMP-dependent pathways, the NF-kappaB signaling pathway and the ERK1/2, p38 MAPK, AP-1/NFAT pathway. | Morphine | mitogen-activated protein kinase 3 | Mus musculus |